Pharmacokinetics of Nirmatrelvir/Ritonavir after Multiple Administration in a Phase 1, Open-Label Study in Healthy Chinese Adults and Compared with Non-Chinese Participants.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42090083

Chunye Zhang; Jackie Gerhart; Jicheng Yu; Jing Zhang; Jufang Wu; Nanyang Li; Shuangchen Cong; Xiaoran Han; Ying Ma

May 6, 2026